What happens if you take too much Ozempic or Wegovy?

Translate to Spanish or other 102 languages!

Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss. Image for illustration purposes
Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss. Image for illustration purposes
- Advertisement -
  • Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss.
  • Reports of inadvertent overdoses have led to hospitalizations in some cases, with symptoms including intense nausea, vomiting and abdominal discomfort.
  • Data from America’s Poison Centers reveals a startling 15-fold increase in semaglutide-related calls between January and November, primarily attributed to dosage errors, amid concerns over the safety of compounded formulations of the drug.

Semaglutide, a glucagon-like peptide-1 receptor agonist or GLP-1 analog, gained approval from the Food and Drug Administration (FDA) in 2017.

The medicine is marketed as Ozempic for diabetes management and Wegovy for weight loss.

Folllow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/what-happens-if-you-take-too-much-ozempic-or-wegovy

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What Is Your Baby Trying to Tell You?

Coughing is one of our bodies' most important defenses against respiratory illnesses like the flu and pneumonia. It helps clear mucus in the airways and can prevent an infection from moving deeper into the airway and lungs.

Preventing Carbon Monoxide Exposure

Mega Doctor News CLEVELAND CLINIC - With cooler weather here to stay and...

New Mount Sinai Trial Improves Coronary Stent Expansion

A randomized clinical trial at The Mount Sinai Hospital found that combining two techniques for removing calcium nodules—rotational atherectomy and intravascular lithotripsy (IVL)—before coronary stent placement allowed stents to expand more fully than IVL alone in patients with calcified coronary nodules.  

STHS to Host Webinar on Link Between Gut Health & Overall Well-Being, Nov. 17th 

When it comes to maintaining good health, the gut often doesn't get the attention it deserves. Frequently called the body's "second brain," the digestive system does far more than process food.
- Advertisement -